Oncology

Total pancreatectomy with islet cell autologous transplantation: A treatment modality for patients with chronic pancreatitis pain

ONE IN FIVE patients diagnosed with acute pancreatitis will develop recurrent acute pancreatitis, and one in three of them will develop chronic pancreatitis (CP),...

Healthy Nurse Healthy Nation Year Two Highlights

On May 1, 2017, ANA Enterprise launched a bold initiative—Healthy Nurse, Healthy NationTM (HNHN) Grand Challenge—to transform the health of our nation by first...

Radiology nursing: A growing specialty

Find out if you have what it takes to pursue this fast-paced career path. Takeaways:  Radiology nursing is a little-known specialty that’s not always an...

Colorectal cancers on the rise…in young adults

By Julie Cullen, Managing Editor, American Nurse Today Research coming out of the United States and Canada is showing an increase in colorectal cancers among...

ANA on the Frontline: Sparks fly at ANA-ANCC conferences

Nurses come together to improve practice, work environments, and healthcare. While one speaker encouraged nurses to find their “inner spark,” the energy among nurses was...

Restoration rooms

A safe place for nurses to recharge SOMETIMES, 10 to 15 minutes of quiet time in a comfortable space is all it takes to recharge....

Centralized vs decentralized staffing: Two case studies

Strive for balance to achieve improved outcomes. Takeaways:  Nurse staffing is influenced by an organization’s structure and culture.  Centralized staffing manages staffing through a central...

FDA approves first PI3K inhibitor for breast cancer

On May 24, the FDA approved Piqray (alpelisib) tablets, to be used in combination with fulvestrant, to treat postmenopausal women, and men, with hormone...

Evidence-based practices for osteoarthritis management

Self-management education is the foundation of osteoarthritis care. Takeaways: · Osteoarthritis is a chronic disorder of the joints that is painful, prevalent, costly, and a leading...

FDA approves first targeted therapy for bladder cancer

On April 12, the FDA approved Balversa (erdafitinib) for adult patients with locally advanced or metastatic bladder cancer that has a susceptible genetic alteration...